National Cancer Institute; Notice of Closed Meetings, 42718 [2011-18142]

Download as PDF 42718 Federal Register / Vol. 76, No. 138 / Tuesday, July 19, 2011 / Notices Number of respondents Reporting document Responses per respondent Total responses Burden per response Total burden hours Application and Report without Needs Assessment (2012, 2013 & 2014) .................................................................... 59 1 59 246 14,514 Total .............................................................................. 59 1 59 246 14,514 E-mail comments to paperwork@hrsa.gov or mail the HRSA Reports Clearance Officer, Room 10–33, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Written comments should be received within 60 days of this notice. Dated: July 13, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4165–15–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health Cancellation of Meeting National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting sroberts on DSK5SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Consortium of Lung Repair and Regeneration: Building the Foundation, Administration and Coordination Center. Date: August 5, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: YingYing Li-Smerin, MD, PhD, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892– 7924, 301–435–0277, lismerin@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and 17:20 Jul 18, 2011 Jkt 223001 Dated: July 13, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–18147 Filed 7–18–11; 8:45 am] [FR Doc. 2011–18105 Filed 7–18–11; 8:45 am] VerDate Mar<15>2010 Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Notice is hereby given of the cancellation of the National Institute of Mental Health Special Emphasis Panel, July 20, 2011, 1:30 p.m. to July 20, 2011, 2:30 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD, 20852 which was published in the Federal Register on July 7, 2011, 76FR39884. This meeting is being canceled due to the lone application being withdrawn. Dated: July 12, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–18059 Filed 7–18–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00045 Fmt 4703 Sfmt 9990 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Therapies. Date: October 13–14, 2011. Time: 8 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/DC Rockville, Hotel and Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20582. Contact Person: Delia Tang, MD, Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8123, MSC 8328, Bethesda, MD 20892, 301–496–2330, tangd@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, K08 Grant Applications. Date: October 13, 2011. Time: 5 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Crystal City, 2799 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Sergei Radaev, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8113, Bethesda, MD 20892, 301–435– 5655, sradaev@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: July 13, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–18142 Filed 7–18–11; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 76, Number 138 (Tuesday, July 19, 2011)]
[Notices]
[Page 42718]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18142]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Therapies.
    Date: October 13-14, 2011.
    Time: 8 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/DC Rockville, Hotel and Executive 
Meeting Center, 1750 Rockville Pike, Rockville, MD 20582.
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Blvd., Room 8123, MSC 8328, Bethesda, MD 20892, 301-496-
2330, tangd@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, K08 Grant Applications.
    Date: October 13, 2011.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Crystal City, 2799 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Sergei Radaev, PhD, Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8113, Bethesda, MD 20892, 301-435-5655, 
sradaev@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-18142 Filed 7-18-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.